- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07245849
Perikardbildstudie
Identifiering av kliniska, serum- och bildbaserade biomarkörer associerade med högriskfenotyper för återkommande perikardit: En prospektiv kohortstudie
The pericardium is a thin, double-layered sac around the heart that helps reduce friction as the heart moves. When this sac gets inflamed, it is called pericarditis, which can cause serious health problems and even be life-threatening. Pericarditis often comes back after the first episode. About 10-30% of people will have it again, and half of those will have it multiple times. Although there are treatments available, they are costly and not often used because we can't predict who best to use them on. Finding a way to predict which patients would benefit from these treatments could help reduce the burden on patients and the healthcare system.
This study will use a test called an 18F-FDG PET/CT with CTA Scan (18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) with computer tomography angiography (CTA)) to measure inflammation in the pericardium.
The purpose of the study is to create easy-to-use tools for doctors to identify people at high risk of pericarditis coming back, so they can get advanced treatment early. This study will help fill knowledge gaps about key predictors like clinical signs, blood tests, and imaging results.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This is a single-center, prospective cohort study designed to compare imaging biomarkers identified by CMR and FDG PET between patients who experience recurrent pericarditis and those who do not. In this prospective study, 44 patients will be recruited from the Ottawa Pericardial Clinic, all with a history of recurrent pericarditis. These patients will be followed prospectively for a period of one year.
It is hypothesized that patients who develop further episodes of recurrent pericarditis will exhibit significantly elevated markers of pericardial inflammation on both FDG PET/CT imaging as well as CMR imaging.
Studietyp
Inskrivning (Beräknad)
Fas
- Fas 3
Kontakter och platser
Studiekontakt
- Namn: Kevin Boczar, MD
- Telefonnummer: 613-696-7083
- E-post: KBoczar@ottawaheart.ca
Studera Kontakt Backup
- Namn: Ashley Cowan, RN
- E-post: pmacphee@ottawaheart.ca
Studieorter
-
-
Ontario
-
Ottawa, Ontario, Kanada, K1Y 4W7
- Rekrytering
- University of Ottawa Heart Institute
-
Kontakt:
- Ashley Cowan, RN
- Telefonnummer: 6136967000
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
-
History of recurrent pericarditis* (i.e. presentation of at lease 2nd episode of acute pericarditis).
-
Age >/= 18 years
-
Given informed consent
- standard definitions will be used to define an episode of pericarditis. Pericarditis will be diagnosed by using available published criteria, which includes typical pericardial chest pain, pericardial friction rubs, widespread ST segment elevation or PR-segment depression that was not previously reported and new or worsening pericardial effusion on echocardiography. A clinical diagnosis of acute pericarditis will be made when at least 3 of these criteria are present.
Exclusion Criteria:
- severe valve disease requiring intervention
- claustrophobia that precludes FDG/PET or CMR imaging
- pregnancy (all women of child bearing potential will have a negative BHCG test)
- breastfeeding
- glomerular filtration rate (GFR) <50 m/min/1.72m2
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Diagnostisk
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Recurrent pericarditis
This is a single arm study. Participants enrolled will complete blood and imaging tests. |
The participants will under an 18F-FDG PET/CT with CTA. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Pericardial contrast uptake on late gadolinium enhancement (LGE) on CMR
Tidsram: At Baseline
|
Pericardial imaging by CMR to evaluate inflammation |
At Baseline
|
|
Circumferential linear increased FDG signal uptake
Tidsram: baseline
|
Pericardial Imaging to indicate pericardial inflammation. |
baseline
|
|
Recurrent pericarditis
Tidsram: From baseline to 1 year
|
# of participants that experience pericarditis recurrence after the qualifying occurrence |
From baseline to 1 year
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Clinical Factor - Age
Tidsram: At Baseline
|
Participant Age |
At Baseline
|
|
Clinical Factor - Sex
Tidsram: At Baseline
|
Sex of participant |
At Baseline
|
|
Clinical Factor - Family history of auto-immune disease
Tidsram: baseline
|
Presence of family history of auto-immune disease |
baseline
|
|
Clinical Factor - Heart Rate
Tidsram: At Baseline
|
Resting Heart rate of >80beats per minute |
At Baseline
|
|
Serum biomarkers - C-Reactive Protein
Tidsram: At Baseline
|
C-Reactive protein levels |
At Baseline
|
|
Serum biomarkers - Erythrocyte sedimentation rate (ESR)
Tidsram: At Baseline
|
ESR level |
At Baseline
|
|
Serum biomarkers - carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1)
Tidsram: At Baseline
|
CEACAM1 levels |
At Baseline
|
|
Serum biomarkers - MHC class I chain related protein A (MICA)
Tidsram: At Baseline
|
MICA levels |
At Baseline
|
|
Serum biomarkers - MHC Class I chain related protein B (MICB)
Tidsram: At Baseline
|
MICB levels |
At Baseline
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 20250237-01H
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .